From: anticree8908989p@gmail.com   
      
   TEXAS IMNATE STUDY (PAGES 24-40) KENNETH MARTIN DOLAN IS DIFFERENT THAN ALL >   
   64 TEXAS INMATES AND NEVER LEGITIMATELY THE SAME AS ALL > 64 TEXAS INMATES   
   THEREFORE KENNETH MARTIN DOLAN CAN NEVER BE LEGITIMATELY AN INMATE AS STATED   
   SINCE AT LEAST 2009    
      
   (PAGES 24 THROUGH 40)    
      
   participation at a second data collection session and that the estimated time   
   for the first    
   session and the second session is approximately two hours for each session.   
   Inmates who    
   were recruited for participation in one testing session were informed that the   
   study asks    
   for participation in one testing session and that the estimated time for the   
   testing session    
   is approximately two hours. Then, the experimenter asked participants to   
   retrieve all    
   testing materials from the manila envelope. Participants were asked to locate   
   the    
   informed consent form. Participants were informed that a copy of the informed   
   consent is    
   available for their review in the Warden’s office. Next, the experimenter   
   read the consent    
   form aloud while participants read along on their copy of the consent form.   
   The    
   experimenter then asked for and addressed participants’ questions. When all   
   questions    
   were answered, the experimenter asked the participants to sign their name on   
   the    
   designated line if they chose to participate. Participants who did not want to   
   continue in    
   the study were excused to return to their normally scheduled assignment. The   
   number of    
   participants who did not participate was recorded by the experimenter (n =   
   556). Once    
   participants completed the informed consent form, the experimenter collected   
   these forms    
   and placed them in an appropriately labeled manila envelope.    
   Next, the experimenter instructed participants to not write any identifying    
   information (e.g., name, social security number, TDCJ number) on any of the   
   remaining    
   testing materials. The experimenter asked the participants to locate and   
   complete the    
   demographic form. Afterwards, participants were asked to return the completed    
   demographic form to the manila envelope and to locate the instructions form   
   and the    
   multiscale inventory. The experimenter explained the format of the   
   inventories. Then, the    
   24    
   experimenter orally presented the instructions as participants read along on   
   their copy of    
   instructions, and asked for and addressed questions from participants. After   
   all questions    
   were addressed, the experimenter asked the participants to complete the   
   multiscale    
   inventory. In addition, the experimenter instructed the participants to place   
   completed    
   testing materials back in the envelope and to return the envelope to the   
   experimenter once    
   all testing materials were completed.    
   When participants brought the envelope to the experimenter after completing   
   the    
   testing materials for the first testing session, they were asked to write   
   their name next to    
   their experimental number on the experimental log if participation involved a   
   second    
   testing session. This log was used in the second testing session to identify   
   participants’    
   manila envelope of testing materials to complete.    
   The second data collection session was conducted in a group testing format in   
   a    
   similar room with tables, desks, or chairs. Once participants began to arrive,   
   the    
   experimenter distributed envelopes and pencils to participants by asking each   
   participant    
   for his name. The experimenter located participants’ experimental number on   
   the    
   experimenter’s log containing experimental numbers and corresponding   
   participant    
   names. After the experimenter located participants’ experimental number, the   
   second    
   manila envelopes were obtained and handed to the proper participants. The   
   participants    
   were asked to retrieve all testing materials from the envelope. The   
   experimenter orally    
   read the instructions for completing the remaining two multiscale inventories   
   and asked    
   participants to return the completed testing materials in the envelope to the   
   experimenter.    
   Next, the experimenter informed participants to not write any identifying   
   information    
   25    
   (e.g., name, social security number, TDCJ number) on any of the testing   
   materials.    
   Finally, the experimenter asked participants to start completing the testing   
   materials.    
   Participants were asked to first complete the multiscale inventory with a   
   number “1” at    
   the top and then to complete the multiscale inventory with a number “2” at   
   the top. When    
   participants finished and returned their envelopes containing the completed   
   testing    
   materials to the experimenter, the experimenter thanked the participants and   
   provided    
   debriefing forms (see Appendix F) to the participants. Participants were asked   
   to read the    
   debriefing forms before they left the testing room. The experimenter answered   
   any    
   questions from participants and retrieved all debriefing forms. Each   
   participant was    
   excused after returning the debriefing form.    
   Confidentiality. All information obtained in this study remained strictly    
   confidential and was not shared or communicated with security, treatment, or   
   support    
   staff. This was accomplished in the following ways. A three-digit experimental   
   number    
   was used to identify participants and their materials for this study.   
   Participants’ testing    
   materials were stored under this three-digit experimental number with no   
   identifying    
   information. A log was kept that contained participants’ experimental   
   numbers and    
   corresponding names. Moreover, the informed consent form, which contained the    
   participant’s name, has no experimental number. If a participant wrote any   
   identifying    
   information on any of the testing materials except for the informed consent   
   form, then the    
   experimenter blotted it out with a permanent black marker. The participants   
   were orally    
   reminded by the experimenter during the administration of testing materials to   
   refrain    
   from writing any identifying information on the relevant testing materials.   
   Furthermore,    
   26    
   the experimenter collected participants’ informed consent forms, which were   
   the only    
   materials that contained any identifying information, and placed them in an   
   envelope that    
   was kept separate from other testing materials. The log with participants’   
   names and    
   experimental numbers was electronically shredded within two weeks of   
   participants    
   completing data collection.    
      
   [continued in next message]   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)